Vitalograph is proud to announce that it a FeNO by NIOX® UK channel partner.
Spirometry and FeNO present physicians with complementary diagnostic data to inform asthma care pathways.
NIOX VERO® is non-invasive, simple-to-use, and provides rapid standardised FeNO measurements. It is a point-of-care device for assessing airway inflammation in patients with respiratory problems. With over 45 million NIOX® tests undertaken to date, the system is used by healthcare professionals around the world to help improve asthma care. FeNO testing is now recommended for asthma care in guidelines across the globe.
“This collaboration will offer UK healthcare providers additional access to NIOX® products and services to help enhance patient outcomes,” said Steven Adair, Business Manager, NIOX® UK & Ireland.
Adrian Fineberg, EVP PFT Solutions for Vitalograph, said: “The addition of FeNO is an exciting complement to our respiratory portfolio. The NIOX VERO® fits perfectly with our line-up of technologically advanced solutions for diagnosing and managing asthma.”
Discover the NIOX VERO®
Find out more about NIOX
